Elon Musk endorsed Novo Nordisk's Ozempic, a drug primarily for Type 2 diabetes, as a solution to childhood obesity, sparking a conversation on the topic. Musk's support for Ozempic, highlighted in a response to a post about obesity policies on X, brings attention to the obesity issue in the U.S. and Japan. Novo Nordisk, the maker of Ozempic, has also launched Wegovy in Japan to address obesity, amidst concerns over the high cost of these drugs.